Clearstead Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
247,495
+11,295
| +5% | +$29.8K | 0.01% | 533 |
|
|
2025
Q1 | $711K | Buy |
236,200
+20,000
| +9% | +$60.2K | 0.01% | 487 |
|
|
2024
Q4 | $553K | Buy |
216,200
+10,200
| +5% | +$26.1K | 0.01% | 551 |
|
|
2024
Q3 | $766K | Buy |
206,000
+17,500
| +9% | +$65.1K | 0.01% | 476 |
|
|
2024
Q2 | $1.19M | Buy |
+188,500
| New | +$1.19M | 0.02% | 354 |
|